Browsing by Author "Petty, R. D."

Now showing 1 - 2 of 2

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma : a translational analysis of the DEBIOC clinical trial
(2024-11) Scanlon, E.; Lavery, A.; Albraikat, M.; Stevenson, L.; Kennedy, C.; Byrne, R.; Walker, A.; Mullan-Young, B.; McManus, D. T.; Virdee, P. S.; Elhussein, L.; Turbitt, J.; Collinson, D.; Miedzybrodzka, Z.; Van Schaeybroeck, S.; McQuaid, S.; James, J. A.; Craig, S. G.; Blayney, J. K.; Petty, R. D.; Harkin, D. P.; Kennedy, R. D.; Eatock, M. M.; Middleton, M. R.; Thomas, A.; Turkington, R. C.; University of Aberdeen.Medical Genetics Group; University of Aberdeen.Medical Sciences; University of Aberdeen.Applied Medicine
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
(2024-05) Baxter, M. A.; Spender, L. C.; Cairns, D.; Walsh, S.; Oparka, R.; Porter, R. J.; Bray, S.; Skinner, G.; King, S.; Turbitt, J.; Collinson, D.; Miedzybrodzka, Z. H.; Jellema, G.; Logan, G.; Kennedy, R. D.; Turkington, R. C.; McLean, M. H.; Swinson, D.; Grabsch, H. I.; Lord, S.; Seymour, M. J.; Hall, P. S.; Petty, R. D.; University of Aberdeen.Applied Medicine